In ESCC, NORAD depletion can be used in combination with radiotherapy for sensitizing radiotherapy-resistant ESCC cells in a colony formation assay, suggesting that NORAD can be an effective target to enhance the cytotoxic effects of radiation in ESCC patients [111]. Here, NORAD is linked to esophageal squamous cell carcinoma.